MX358845B - Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel. - Google Patents
Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel.Info
- Publication number
- MX358845B MX358845B MX2015014265A MX2015014265A MX358845B MX 358845 B MX358845 B MX 358845B MX 2015014265 A MX2015014265 A MX 2015014265A MX 2015014265 A MX2015014265 A MX 2015014265A MX 358845 B MX358845 B MX 358845B
- Authority
- MX
- Mexico
- Prior art keywords
- glutamine
- hyaluronic acid
- alanine
- skin lesions
- healing wounds
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 2
- 206010052428 Wound Diseases 0.000 title abstract 2
- 208000027418 Wounds and injury Diseases 0.000 title abstract 2
- 230000035876 healing Effects 0.000 title abstract 2
- 229920002674 hyaluronan Polymers 0.000 title abstract 2
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 2
- 231100000444 skin lesion Toxicity 0.000 title abstract 2
- 206010040882 skin lesion Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000011885 synergistic combination Substances 0.000 title 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 abstract 1
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- 229960002648 alanylglutamine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Birds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polymers & Plastics (AREA)
Abstract
La presente invención se refiere a una combinación que comprende el dipéptido L-alanil-L-5 glutamina, ácido hialurónico o una de las sales del mismo y un extracto de avena, destinada ventajosamente para la curación de heridas y la reparación de lesiones de la piel.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1353231A FR3004353B1 (fr) | 2013-04-10 | 2013-04-10 | Association synergique de l'alanine-glutamine, l'acide hyaluronique et un extrait d'avoine, et son utilisation dans une composition destinee a la cicatrisation et la reparation des lesions cutanees |
| PCT/EP2014/057224 WO2014167039A1 (fr) | 2013-04-10 | 2014-04-10 | Association synergique de l'alanine-glutamine, l'acide hyaluronique et un extrait d'avoine et son utilisation dans une composition destinee a la cicatrisation et la reparation des lesions cutanees |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015014265A MX2015014265A (es) | 2016-03-01 |
| MX358845B true MX358845B (es) | 2018-09-05 |
Family
ID=48741402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015014265A MX358845B (es) | 2013-04-10 | 2014-04-10 | Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9849154B2 (es) |
| EP (1) | EP2983691B1 (es) |
| JP (1) | JP2016515642A (es) |
| KR (1) | KR102202391B1 (es) |
| CN (1) | CN105101984B (es) |
| AU (1) | AU2014253131B2 (es) |
| BR (1) | BR112015024920A2 (es) |
| CA (1) | CA2908628C (es) |
| DK (1) | DK2983691T3 (es) |
| ES (1) | ES2661908T3 (es) |
| FR (1) | FR3004353B1 (es) |
| MX (1) | MX358845B (es) |
| NO (1) | NO2983691T3 (es) |
| PL (1) | PL2983691T3 (es) |
| PT (1) | PT2983691T (es) |
| RU (1) | RU2665371C2 (es) |
| WO (1) | WO2014167039A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3066693B1 (fr) * | 2017-05-24 | 2020-12-18 | Fabre Pierre Dermo Cosmetique | Composition pour le remodelage des cicatrices |
| KR101899413B1 (ko) * | 2018-05-03 | 2018-09-18 | 주식회사 케어사이드 | 피부 감염의 예방 또는 치료용 조성물 |
| US10500318B1 (en) * | 2018-07-03 | 2019-12-10 | Temple Therapeutics BV | Dosing regimens for treating hypoxia-associated tissue damage |
| KR102022400B1 (ko) * | 2019-04-30 | 2019-09-18 | (주)진셀팜 | 천연 복합 추출물을 유효성분으로 함유하는 안티폴루션 화장료 조성물 |
| KR102850158B1 (ko) * | 2023-06-13 | 2025-08-22 | 주식회사 엘지생활건강 | 피부 관리 조성물 |
| FR3159323A1 (fr) | 2024-02-15 | 2025-08-22 | Pierre Fabre Dermo-Cosmetique | Nouvelles compositions cosmétiques pour les peaux lésées |
| FR3162631A1 (fr) | 2024-05-30 | 2025-12-05 | Pierre Fabre Dermo-Cosmetique | Nouvelles compositions cosmétiques pour la réparation cutanée |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6368579B1 (en) * | 2000-08-08 | 2002-04-09 | Teresa Leigh Barr | Oat protein complex sunblock and method of use |
| DK2656832T3 (en) * | 2006-05-11 | 2019-04-08 | Regenics As | Compositions for use in wound healing |
| FR2926461B1 (fr) * | 2008-01-23 | 2010-03-05 | Jean Noel Thorel | Nouveau facteur de croissance cellulaire d'origine non animale et applications |
| FR2938439B1 (fr) | 2008-11-14 | 2013-03-01 | Fabre Pierre Dermo Cosmetique | Extrait de parties aeriennes d'avoine recoltees avant epiaison |
| DE102009029813A1 (de) * | 2009-06-18 | 2010-12-23 | Henkel Ag & Co. Kgaa | Antifalten-Kosmetikum |
| CN101816620B (zh) * | 2010-03-12 | 2011-07-20 | 广州舒泰生物技术有限公司 | 一种美白化妆品及其制备方法和应用 |
| RU2578426C2 (ru) * | 2010-06-28 | 2016-03-27 | Эдитерапьютикс, Инк. | Лечение келоидов |
| DE102010027180A1 (de) * | 2010-07-14 | 2011-05-26 | Henkel Ag & Co. Kgaa | Nicht-therapeutische Verwendung zum Stammzellenschutz |
| JP2012240993A (ja) | 2011-05-24 | 2012-12-10 | Q P Corp | 肌弾力性改善剤 |
| FR2977494B1 (fr) * | 2011-07-08 | 2013-08-16 | Ayawane | Compositions cosmetiques ou pharmaceutiques contenant des acides hyaluroniques de masses moleculaires differentes |
-
2013
- 2013-04-10 FR FR1353231A patent/FR3004353B1/fr active Active
-
2014
- 2014-04-10 PT PT147168090T patent/PT2983691T/pt unknown
- 2014-04-10 BR BR112015024920A patent/BR112015024920A2/pt not_active IP Right Cessation
- 2014-04-10 AU AU2014253131A patent/AU2014253131B2/en active Active
- 2014-04-10 US US14/777,989 patent/US9849154B2/en active Active
- 2014-04-10 DK DK14716809.0T patent/DK2983691T3/en active
- 2014-04-10 NO NO14716809A patent/NO2983691T3/no unknown
- 2014-04-10 WO PCT/EP2014/057224 patent/WO2014167039A1/fr not_active Ceased
- 2014-04-10 MX MX2015014265A patent/MX358845B/es active IP Right Grant
- 2014-04-10 KR KR1020157031150A patent/KR102202391B1/ko active Active
- 2014-04-10 PL PL14716809T patent/PL2983691T3/pl unknown
- 2014-04-10 RU RU2015142443A patent/RU2665371C2/ru active
- 2014-04-10 JP JP2016506968A patent/JP2016515642A/ja not_active Withdrawn
- 2014-04-10 CN CN201480020226.6A patent/CN105101984B/zh active Active
- 2014-04-10 EP EP14716809.0A patent/EP2983691B1/fr active Active
- 2014-04-10 CA CA2908628A patent/CA2908628C/fr active Active
- 2014-04-10 ES ES14716809.0T patent/ES2661908T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014253131B2 (en) | 2018-11-15 |
| KR102202391B1 (ko) | 2021-01-12 |
| DK2983691T3 (en) | 2018-03-19 |
| US20160303181A1 (en) | 2016-10-20 |
| FR3004353A1 (fr) | 2014-10-17 |
| BR112015024920A2 (pt) | 2017-07-18 |
| RU2665371C2 (ru) | 2018-08-29 |
| FR3004353B1 (fr) | 2015-05-15 |
| EP2983691B1 (fr) | 2017-12-13 |
| WO2014167039A1 (fr) | 2014-10-16 |
| HK1212924A1 (zh) | 2016-06-24 |
| RU2015142443A (ru) | 2017-05-19 |
| CN105101984A (zh) | 2015-11-25 |
| EP2983691A1 (fr) | 2016-02-17 |
| JP2016515642A (ja) | 2016-05-30 |
| CN105101984B (zh) | 2018-06-01 |
| KR20150140319A (ko) | 2015-12-15 |
| NO2983691T3 (es) | 2018-05-12 |
| CA2908628A1 (fr) | 2014-10-16 |
| PT2983691T (pt) | 2018-03-22 |
| CA2908628C (fr) | 2021-06-08 |
| US9849154B2 (en) | 2017-12-26 |
| ES2661908T3 (es) | 2018-04-04 |
| AU2014253131A1 (en) | 2015-11-05 |
| PL2983691T3 (pl) | 2018-05-30 |
| MX2015014265A (es) | 2016-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015014265A (es) | Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel. | |
| CA2897514C (en) | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring | |
| MX2021014242A (es) | Uso de linagliptina en terapia antidiabetica cardio- y renoprotectora. | |
| PH12016500511A1 (en) | Selective grp94 inhibitors and uses thereof | |
| BR112015011756A2 (pt) | inibidores da glutamase e métodos de uso | |
| IL257057A (en) | Biologically active peptides derived from soy for use in preparations and methods for wound healing, tissue engineering and regenerative medicine | |
| MX2021001169A (es) | Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas. | |
| MX359181B (es) | Hidrolizado de colágeno y uso del mismo. | |
| CR20120508A (es) | PROTEÍNA DE FUSIÓN ROBO1-Fc Y SU UTILIZACIÓN EN EL TRATAMIENTO DE TUMORES | |
| HK1216833A1 (zh) | 組織擴張器、移植物及使用方法 | |
| PL3226854T3 (pl) | Kompozycja na bazie aminokwasów do odbudowy fibroelastyny w tkance łącznej skóry | |
| BR112015023987A2 (pt) | creme dental de duas fases | |
| PH12015502405B1 (en) | Methods and compositions for wound healing | |
| MX2020011880A (es) | Regeneracion de tejido da?ado. | |
| AU350280S (en) | Apparatus for skin treatment | |
| MX2014010940A (es) | El uso de antitrombina en el tratamiento de preeclampsia. | |
| MX383944B (es) | Composiciones para el cuidado personal. | |
| UA117933C2 (uk) | Поліпептид, здатний зв'язувати с5-компонент комплементу людини | |
| MX374220B (es) | Nepentesina para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados. | |
| BR112014000795A2 (pt) | uso cosmético e/ou dermatológico de compostos oligossacarídeos na prevenção e no tratamento de estrias | |
| MX2015013755A (es) | Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis. | |
| MX385322B (es) | Uso de sedoheptulosa para la prevención y tratamiento de inflamación. | |
| EP3881845A3 (en) | Combination of trazodone and gabapentin for the treatment of pain | |
| FI20155045A7 (fi) | Havupuun pihka steriilin tulehduksen hoitamiseksi ja ennaltaehkäisemiseksi | |
| EP3040343A4 (en) | Low molecular polypeptide for preventing and treating inflammation and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |